Related references
Note: Only part of the references are listed.Harnessing Natural Killer Immunity in Metastatic SCLC
Sarah A. Best et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
Catherine S. Forconi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Hirokazu Taniguchi et al.
FRONTIERS IN ONCOLOGY (2020)
Immunotherapy for small cell lung cancer: mechanisms of resistance
Gerhard Hamilton et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
Xiaoliang Zhao et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu-Chao Zhang et al.
NATURE COMMUNICATIONS (2019)
Role of TGF beta 3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma
Hui-fang Zhu et al.
ONCOGENESIS (2019)
Immune Cell Infiltration Is a Strong Prognostic Indicator in Surgical Resection of SCLC
Ningning Zhou et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
The role of immunotherapy in small cell lung cancer
A. Calles et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer
Emilie Picard et al.
ONCOIMMUNOLOGY (2019)
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
Lazar Vujanovic et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circulating CD56bright NK cells inversely correlate with survival of melanoma patients
Kaat de Jonge et al.
SCIENTIFIC REPORTS (2019)
Role of natural killer cells in lung cancer
Ozge Nur Aktas et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility
Min Yu et al.
ONCOGENE (2018)
Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
Ross A. Soo et al.
Oncotarget (2018)
Targeted Therapy and Immune Therapy for Small Cell Lung Cancer
Shirish M. Gadgeel
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Unravelling the biology of SCLC: implications for therapy
Joshua K. Sabari et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages
Jessica Hoppstaedter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Emerging Role of PML Nuclear Bodies in Innate Immune Signaling
Myriam Scherer et al.
JOURNAL OF VIROLOGY (2016)
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases
Yu Zhang et al.
ONCOTARGETS AND THERAPY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Carolina Vizcaino et al.
PHARMACOLOGY & THERAPEUTICS (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Histologic Assessment of Tumor-Associated CD45(+) Cell Numbers Is an Independent Predictor of Prognosis in Small Cell Lung Cancer
Wei Wang et al.
CHEST (2013)
Breast cancer-derived transforming growth factor- and tumor necrosis factor- compromise interferon- production by tumor-associated plasmacytoid dendritic cells
Vanja Sisirak et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phenotypical analysis, relation to malignancy and prognostic relevance of ICOS plus T regulatory and dendritic cells in patients with gliomas
Konstantinos Gousias et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci
Lee M. Krug et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
Sana Intidhar Labidi-Galy et al.
ONCOIMMUNOLOGY (2012)
Targeting inflammation using selective glucocorticoid receptor modulators
Karolien De Bosscher et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
New insights into the robe of PML in tumour suppression
P. Salomoni et al.
CELL RESEARCH (2008)
Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses
Alexander Faith et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell lines
JS Löpez-González et al.
LUNG CANCER (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Share Paper
